Tags |
|
|
Links |
|
|
Subjects - Effortless Networking: Knowing When to Stop Talking!
A common concern in business networking is how to initiate conversations. Obviously, being able to start a conversation is important, since networking is all ab
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
out having successful conversations.
However, knowing when to *stop* talking is just as important as knowing how to start talking!
Why is this?
I worked with a client once who was so focused on the point she wanted to make that she often didn't realize how her words affected the listeners. As a result,
However, knowing when to *stop* talking is just as important as knowing how to start talking!
Why is this?
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
ng>
Well, because you may want to know
Well, because you may want to know
- whether the other person is interested in what you're saying and if they're "getting it"
- how to refra
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
me the conversation, if necessary
what to say next and in how much detail
and so on...
When you're talking, there's usually someone listen
When you're talking, there's usually someone listen
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ing (we hope!). And if you don't know what is of interest to the other person, you run the risk of saying a lot without getting through. Or worse, having a nega
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
tive impact.
So how often do you pause to listen? How do you know how much to say, and when to stop talking? How do you know when to start talking again?
Thes
So how often do you pause to listen? How do you know how much to say, and when to stop talking? How do you know when to start talking again?
Thes
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
e are some of the questions we address in depth when I work with clients privately. In this article, let me give you a brief overview to get you started.
One s
One s
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
imple way to recognize exactly when to stop talking is to make sure you look at the person you're talking with.
Here's what I mean:
Here's what I mean:
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
I worked with a client once who was so focused on the point she wanted to make that she often didn't realize how her words affected the listeners. As a result,
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
she'd often lose people's attention, and at times even offend people unintentionally.
Clearly, this was a big liability for her. And she was so committed to s
Clearly, this was a big liability for her. And she was so committed to s
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
olving this problem that she proactively asked people around her for feedback. Yet this problem remained only partially solved -- because the feedback she got w
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
as "after the fact", and she still had to "back pedal" often.
During our conversation, I discovered that with email communications she didn't have this problem
During our conversation, I discovered that with email communications she didn't have this problem
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
. No blunders here.
"Why is this?" I asked.
"Because I can see what I've written, so I can edit it and soften it before sending it."
"So, what do you do when
"Why is this?" I asked.
"Because I can see what I've written, so I can edit it and soften it before sending it."
"So, what do you do when
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
you're talking with someone?" I asked. "Where do you usually look?"
"At my notes, or at the whiteboard or screen if I'm making a presentation", she said.
"At my notes, or at the whiteboard or screen if I'm making a presentation", she said.
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
rong>"Well, how about you make it a habit to look directly at the person you're talking with?
- During in-person conversations, practice looki
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
ng at people's facial expressions while you're speaking with them.
If it's a phone conversation, practice listening to their tone of voice and any pau
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
ses.
This way you'll get real time feedback which will help you decide when to stop talking and 'check in' with the listener, or wha
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
t to say or do next."
There was silence.
When she spoke again, she was clearly moved. "Such a simple thing, and yet I never thought of it! And I know
There was silence.
When she spoke again, she was clearly moved. "Such a simple thing, and yet I never thought of it! And I know
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
already that it will make a difference."
Whether you're trying to promote your business or trying to help someone in your network generate more busine
Whether you're trying to promote your business or trying to help someone in your network generate more busine
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
ss, knowing when to stop talking and "check in" with the listener is critical.
So try this out yourself, and see what difference it makes to your conversations
So try this out yourself, and see what difference it makes to your conversations
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.subjects.org.ua/article/31985/subjects-Effortless-Networking-Knowing-When-to-Stop-Talking.html">Effortless Networking: Knowing When to Stop Talking!</a>
BB link (for phorums):
[url=http://www.subjects.org.ua/article/31985/subjects-Effortless-Networking-Knowing-When-to-Stop-Talking.html]Effortless Networking: Knowing When to Stop Talking![/url]
Related Articles:
Online High Risk Merchant Accounts
Malcolm Baldrige Values and Concepts Part 11 – Systems Perspective
Executive Gifts Including Printed Umbrellas
Bookmark it:
|